Glycomimetics for the inhibition and modulation of lectins

S Leusmann, P Ménová, E Shanin, A Titz… - Chemical Society …, 2023 - pubs.rsc.org
Carbohydrates are essential mediators of many processes in health and disease. They
regulate self-/non-self-discrimination, are key elements of cellular communication, cancer …

Biological functions and analytical strategies of sialic acids in tumor

X Zhou, G Yang, F Guan - Cells, 2020 - mdpi.com
Sialic acids, a subset of nine carbon acidic sugars, often exist as the terminal sugars of
glycans on either glycoproteins or glycolipids on the cell surface. Sialic acids play important …

Sialic acid–binding immunoglobulin-like lectins (Siglecs) detect self-associated molecular patterns to regulate immune responses

H Läubli, A Varki - Cellular and Molecular Life Sciences, 2020 - Springer
The mammalian immune system evolved to tightly regulate the elimination of pathogenic
microbes and neoplastic transformed cells while tolerating our own healthy cells. Here, we …

Siglec signaling in the tumor microenvironment

EJH van Houtum, C Büll, LAM Cornelissen… - Frontiers in …, 2021 - frontiersin.org
Sialic acid-binding immunoglobulin-like lectins (Siglecs) are a family of receptors that
recognize sialoglycans–sialic acid containing glycans that are abundantly present on cell …

Hypersialylation in cancer: modulation of inflammation and therapeutic opportunities

E Rodrigues, MS Macauley - Cancers, 2018 - mdpi.com
Cell surface glycosylation is dynamic and often changes in response to cellular
differentiation under physiological or pathophysiological conditions. Altered glycosylation on …

CD22: a regulator of innate and adaptive B cell responses and autoimmunity

EA Clark, NV Giltiay - Frontiers in immunology, 2018 - frontiersin.org
CD22 (Siglec 2) is a receptor predominantly restricted to B cells. It was initially characterized
over 30 years ago and named “CD22” in 1984 at the 2nd International workshop in Boston …

Siglec ligands

A Gonzalez-Gil, RL Schnaar - Cells, 2021 - mdpi.com
A dense and diverse array of glycans on glycoproteins and glycolipids decorate all cell
surfaces. In vertebrates, many of these carry sialic acid, in a variety of linkages and glycan …

Targeting sialic acid–Siglec interactions to reverse immune suppression in cancer

OJ Adams, MA Stanczak, S von Gunten, H Läubli - Glycobiology, 2018 - academic.oup.com
Abstract Changes in sialic acids in cancer have been observed for many years. In particular,
the increase of sialoglycan density or hypersialylation in tumors has been described. Recent …

The CD33 short isoform is a gain-of-function variant that enhances Aβ1–42 phagocytosis in microglia

A Bhattacherjee, J Jung, S Zia, M Ho… - Molecular …, 2021 - Springer
Background CD33 is genetically linked to Alzheimer's disease (AD) susceptibility through
differential expression of isoforms in microglia. The role of the human CD33 short isoform …

CD33 recruitment inhibits IgE-mediated anaphylaxis and desensitizes mast cells to allergen

S Duan, CJ Koziol-White, WF Jester… - The Journal of …, 2021 - Am Soc Clin Investig
Allergen immunotherapy for patients with allergies begins with weekly escalating doses of
allergen under medical supervision to monitor and treat IgE mast cell–mediated …